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1) It might require the elaborate generation of genetically modified human cell lines. This impedes a more systematic analysis of splice mutations for a single gene.
2) Many native cell types are highly specialized and their cultured counterparts (if available at all) do not reflect every morphological and molecular hallmark of the native cells including the composition and activity of the splicing machinery.
3) The generation of humanized animal models expressing the respective splice mutation in a given tissue is not only technically challenging, but also time-consuming and costly. Therefore, this approach also appears rather unsuitable for systematic testing of splice mutations for a given gene. 4) Often, native genes are too large to be cloned into classical expression vectors.
One alternative to circumvent a number of these obstacles is to use human minigenes designed for expression in appropriate animal models (e.g., mouse). We have evaluated this approach in recent studies addressing the effects of disease-associated mutations in different genes, e.g., PRPH2, on mRNA splicing (Becirovic et These vectors are capable of transducing a variety of different cell types in vivo (Zincarelli et al., 2008; Lisowski et al., 2014) . Furthermore, the design, cloning, production and purification of rAAV vectors can be completed in a few weeks and does not require elaborate technical equipment (Becirovic et al., 2016a ).
Most native genes including PRPH2 exceed the limited packaging capacity of AAVs (approx. 4.7 kb) (Wu et al., 2010) . Therefore, we designed PRPH2 minigenes lacking large intronic parts, which usually do not contain information required for correct mRNA splicing. For genes which do not contain large exon numbers or sizes, shortening of the intronic sections also allows for introducing the entire protein coding region into the rAAV vector-based minigenes.
This strategy (cf. Figure 1) was developed and evaluated to analyze the impact of known diseaselinked mutations on mRNA splicing and protein expression in photoreceptor-specific genes, but should in principle also be transferable to other cell types. Copyright In many cases, initial in silico prediction of mRNA splicing of the single mutations might be helpful.
To predict the potential effects on splicing of your mutation of interest use a human splicing finder software (e.g., http://www.umd.be/HSF3/).
1. Go to http://www.umd.be/HSF3/ and select an analysis type. We recommend using the option 'Analyze a sequence'. 10. Centrifuge for 3 min at 13,000-16,000 x g to pellet the precipitated proteins.
11. Pipet 300 µl isopropanol and 0.5 µl Glycogen Solution (provided in the kit, Materials and Reagents A3) into a clean 1.5 ml Eppendorf tube, and add the supernatant from the previous step by pouring or pipetting carefully. Make sure not to transfer the protein pellet.
12. Mix by inverting the tube gently 50 times or by rotating it for 2.5 min at 20 rpm.
13. Centrifuge at RT for 5 min at 13,000-16,000 x g.
14. Carefully discard the supernatant, and drain the tube by inverting it on a clean piece of absorbent paper, taking care that the pellet remains in the tube.
15. Add 300 µl of 70% ethanol and invert the tube several times to wash the DNA pellet.
16. Centrifuge at RT for 1 min at 13,000-16,000 x g.
17.
Carefully discard the supernatant. Drain the tube on a clean piece of absorbent paper, taking care that the pellet remains in the tube. Allow to air dry for 5 min.
18. Add 100 µl DNA Hydration Solution (provided in the kit, Materials and Reagents A3) and vortex for 5 sec at medium speed to mix.
19. Incubate at 65 °C for 1 h to dissolve the DNA.
20. Incubate at room temperature overnight with gentle shaking. Ensure tube cap is tightly closed to avoid leakage. Samples can then be centrifuged briefly and transferred to a storage tube.
C. Overlap extension PCR for construction and cloning of minigenes

C1. Methodological description and design of overlap primers
To enable minigene-based analysis of mutations on mRNA splicing, large introns can be shortened.
In our recent studies, we validated that approx. However, this method is also suitable for the generation of minigenes with a random number of exons and shortened introns. and run it in 1x TBE buffer. Check for correct amplification.
5. If amplification was successful, i.e., if you see a band of correct size, excise it using a scalpel and put the gel slice into an Eppendorf tube. Purify DNA using the gel extraction kit according to the manufacturer's instructions.
6. Measure the DNA concentration using NanoDrop.
Repeat
Step C2 for all exons. 4. Load all of your PCR reaction on an agarose gel and check for correct amplification.
C3. Overlap extension PCR
5. If amplification was successful, i.e., if you see a band of correct size, excise the band and purify DNA using the gel extraction kit according to the manufacturer's instructions.
7. Repeat Overlap extension PCR to connect the new amplicon with the subsequent amplicon.
For this, use the purified DNA of both amplicons as template; and the forward primer of amplicon #1 and the reverse primer of amplicon #3 as Overlap extension PCR primers.
8. Depending on the number of amplicons to be joined together, Steps 1-7 can be repeated.
9. Use the chosen restriction sites to clone your minigene into the respective expression vector using standard cloning techniques.
10. Check for the correct sequence of the minigene by sequencing (e.g., Eurofins Genomics). 
Notes
